Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Augmentin XR (Amoxicillin; Clavulanate Potassium) Extended-Release Tablets, 1 Gram; Equivalent to 62.5 Milligram Base

TitleDrug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Augmentin XR (Amoxicillin; Clavulanate Potassium) Extended-Release Tablets, 1 Gram; Equivalent to 62.5 Milligram Base
ToC Doc Augmentin XR (Amoxicillin; Clavulanate Potassium) Extended-Release Tablets, 1 Gram; Equivalent to 62.5 Milligram Base
Docket Number2024-22572
Type Notice
Subject Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness:
Augmentin XR (Amoxicillin; Clavulanate Potassium) Extended-Release Tablets, 1 Gram; Equivalent to 62.5 Milligram Base
Publication Date2024-10-02
Last Updated Date 2024-10-01 08:37:58 -0400
Last Public Inspection2024-10-01
Filed At2024-10-01T08:45:00.000-04:00
PDF 2024-22572_PI.pdf (95769 bytes)
Download TXT / HTML / JSON
Number of Pages 3
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021